News from NORD

Foundation for Prader-Willi Research Highlights Study of Genetic Therapy for Prader-Willi Syndrome

Publish date: February 17, 2017

 

The Foundation for Prader-Willi Research has published a blog that discusses a new study which shows promising first steps toward genetic therapy for Prader-Willi syndrome.

Recommended Reading

Rituximab is dramatically effective in IgG4-related disease
MDedge Dermatology
NORD Seeks Input Regarding Patient Protections and ACA
MDedge Dermatology
Rare Disease Day 2017 Will Highlight Research Theme
MDedge Dermatology
NORD to Partner Again With Hole in the Wall Gang Camp
MDedge Dermatology
Apply Now to Join NORD’s Charity Marathon Team
MDedge Dermatology
CORD Offers Consensus Framework for Ethical Collaboration
MDedge Dermatology
NORD Publishes Report on Spontaneous Intracranial Hypotension (SIH)
MDedge Dermatology
Alport Syndrome Foundation Announces Research Funding
MDedge Dermatology
Aplastic Anemia & MDS International Foundation Research Portal Is Open
MDedge Dermatology
APS Type 1 Symposium Is Planned
MDedge Dermatology